Amalgamated Bank Bio Xcel Therapeutics, Inc. Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.95 - $4.04 $4,034 - $8,358	-2,069 Reduced 74.8%	697 $2,000
Q4 2023 Feb 06, 2024	SELL	$2.32 - $5.51 $480 - $1,140	-207 Reduced 6.96%	2,766 $8,000
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $6,076 - $27,179	951 Added 47.03%	2,973 $19,000
Q1 2023 May 02, 2023	SELL	$17.7 - $33.24 $5,628 - $10,570	-318 Reduced 13.59%	2,022 $38,000
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $4,298 - $10,257	-476 Reduced 16.9%	2,340 $31,000
Q1 2022 Jun 30, 2022	BUY	$15.0 - $22.83 $42,240 - $64,289	2,816 New	2,816 $59,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.